Umbilical cord blood transplantation: the first 20 years.
about
Public banking of umbilical cord blood or storage in a private bank: testing social and ethical policy in northeastern Italy.Stem Cell Therapy: A New Treatment for Burns?Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression.Biochemical and Parasitological Studies on the Effect of hUCB-Selected CD34(+) Progenitor/Stem Cells in Mice Infected with Schistosoma mansoni.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.Effects of obstetric factors and storage temperatures on the yield of endothelial colony forming cells from umbilical cord blood.Impact of maternal and neonatal factors on parameters of hematopoietic potential in umbilical cord bloodTherapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growthUS public cord blood banking practices: recruitment, donation, and the timing of consentThe Role of HLA in Cord Blood Transplantation.Exogenous endothelial cells as accelerators of hematopoietic reconstitution.Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury.Concise review: hematopoietic stem cell aging, life span, and transplantation.Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.Plasma-depleted versus red cell-reduced umbilical cord blood.Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario.Proteomic Profiling of Ex Vivo Expanded CD34-Positive Haematopoetic Cells Derived from Umbilical Cord Blood.Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation.Promoting Effects of Heparin on ex vivo Expansion of Megakaryocytopoiesis from Human Cord Blood CD34+ Cells.Stem Cell Therapy for Fanconi Anemia.Awareness and acceptance of public cord blood banking among practicing obstetricians in the United States.Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis.Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity.A novel method of CD34+ cell separation from umbilical cord blood.Pharmacological inhibition of AKT activity in human CD34+ cells enhances their ability to engraft immunodeficient mice.Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease.The circadecadal rhythm of oscillation of umbilical cord blood parameters correlates with geomagnetic activity - An analysis of long-term measurements (1999-2011).Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem celTransient inhibition of NF-κB signaling enhances propagation of human hematopoietic stem cells
P2860
Q33455607-C7F49D6C-F19C-4D4B-9A80-94289F4F0ACBQ33765265-A9BA2BEF-0081-49B1-B35C-95F2D9E77BB8Q34445046-82A21171-8E96-43B9-9C79-BCFD2FEDCC71Q34599776-60395BE1-7BC5-4544-8BC1-6CCAA61A3020Q34622755-F306DD81-0154-40E1-8104-D8AA3E265DD7Q35161308-38FBD4FB-C345-4C3F-865D-2982E83F47CCQ35681181-59901589-F86F-412A-B1B0-2B6F3F0153BEQ36235193-A9687715-4D1B-4E80-9F2A-98F2E98AD17CQ36335783-14DBA33A-6C2A-4247-AD14-6670F77C4B8EQ36336608-114FB4B2-C8D2-4756-A188-7CF4CD4451DCQ36527110-46958708-A995-43A7-A5B3-2B0AFEF6EEF7Q36645434-0D2665B2-1B9E-43E3-921C-95DD7A5804EEQ36861673-448E43AA-F12B-4330-AD1D-B2093D2D2A17Q37325713-C6E87718-B082-4C31-8A98-38E7D52E00A1Q38035452-A1FC87F4-B734-4F01-8664-7886631FF2BCQ38210864-30EFF18A-F3BF-43BC-B160-A887146A21FDQ39529193-4263AC81-E7D5-4F4A-BDEA-6FFB7F390CDBQ39635182-14F6CEDA-3E4C-4FB5-A2FB-21FD090C5A3EQ39743347-42D560E6-969F-4536-BFC6-6C8A7BF5C768Q42241622-A8852DA1-B446-47AB-879A-1030D4455A72Q42915377-33836E20-B873-4466-8095-E65F15084061Q45869566-91ECA0EB-7178-449B-A389-1F60A221BD37Q48106559-5F5BE270-466B-4B5D-AEFA-717558A42C5AQ49080212-7CBE8DF2-059A-4597-B988-14B8912DB275Q50098011-F9C3F792-A842-4097-9EBC-162988FE8A0AQ50494724-A63533C9-D223-4124-9912-D04B2FC5C671Q51488723-D99B7C29-A05F-4B20-B814-3E9556992D9CQ52763837-6E2C5601-E37E-4BD3-901B-955ED2986900Q52860036-A534AD66-0CF2-4FD6-93A4-867CB38E48ABQ54388224-33E9D042-7660-4766-874D-B15A4C3381D5Q58776892-18F104E8-4E13-4E11-B847-1D67DE3DCE44
P2860
Umbilical cord blood transplantation: the first 20 years.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Umbilical cord blood transplantation: the first 20 years.
@en
Umbilical cord blood transplantation: the first 20 years.
@nl
type
label
Umbilical cord blood transplantation: the first 20 years.
@en
Umbilical cord blood transplantation: the first 20 years.
@nl
prefLabel
Umbilical cord blood transplantation: the first 20 years.
@en
Umbilical cord blood transplantation: the first 20 years.
@nl
P1476
Umbilical cord blood transplantation: the first 20 years.
@en
P2093
John E Wagner
P356
10.1053/J.SEMINHEMATOL.2009.10.011
P577
2010-01-01T00:00:00Z